Mitsubishi UFJ Trust & Banking’s Rhythm Pharmaceuticals RYTM Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$429K	Buy	+3,860	New	+$349K	﹤0.01%	1112

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's RYTM Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 3,860 shares worth $429K. The stake represents ﹤0.01% of the portfolio and ranks #1112 among its holdings.

302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 3,860 shares of Rhythm Pharmaceuticals worth $429K as of Q2 2026.
Rhythm Pharmaceuticals was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Rhythm Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1112 holding.
302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.